This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Anterogen Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mi-Hyung Kim: Innovator in Stem Cell Technology
Introduction: Mi-Hyung Kim is an accomplished inventor based in Seoul, South Korea. He is currently associated with Anterogen Co. Ltd., where he focuses on advancements in stem cell technology. His work aims to improve therapeutic applications through innovative formulations and methods.
Latest Patent Applications: Mi-Hyung Kim has made significant contributions through his latest patent applications. One of his notable applications is for an "Injection Formulation Composition Containing Mesenchymal Stem Cell-Hydrogel and Method for Preparing, Freezing and Defrosting Same." This invention relates to a composition that includes injectable mesenchymal stem cell-hydrogel, which enhances the engraftment rate of stem cells by ensuring their stability and viability post-injection. Another important application is for "Autologous and Allogenic Adipose-Derived Stromal Stem Cell Composition for Treating Fistulas." This method efficiently produces clinically effective quantities of human adipose tissue-derived stromal cells, demonstrating superior multipotency and immunomodulatory activity compared to conventional methods.
Conclusion: Mi-Hyung Kim's innovative work in stem cell technology showcases his commitment to advancing medical treatments. His contributions have the potential to significantly impact the field of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile